Shares of Marksans Pharma Ltd were trading in the green and 1.8% higher on 30 May after the company’s subsidiary secured marketing approval. The company stated in a stock exchange filing that the UK Medicines and Healthcare Products Regulatory Agency (UKMHRA) granted market authorisation for the former’s subsidiary Relonchem Ltd Metformin Hydrochloride oral solution in…
February 28, 2025February 28, 2025 Shares of Biocon Ltd slipped 4% on Friday, 28 February, after the company announced that their Glucagon-like Peptide-1 (GLP-1) equivalent, Liraglutide, would be made available in the United Kingdom. The Liraglutide drug will be used to treat diabetes and obesity. With this launch, Biocon…
Shares of Marksans Pharma Ltd were trading in the green and 2% higher on 28 May after the company announced securing approval from the UK health regulators to market new oral solutions. In its regulatory filing, the company said that its wholly-owned subsidiary Reonchem has received the marketing authorisation from UK MHRA for Levetiracetam Relonchem…